NO953832D0 - Cyclic compounds which can be used as inhibitors of platelet glycoprotein IIb / IIIa - Google Patents

Cyclic compounds which can be used as inhibitors of platelet glycoprotein IIb / IIIa

Info

Publication number
NO953832D0
NO953832D0 NO953832A NO953832A NO953832D0 NO 953832 D0 NO953832 D0 NO 953832D0 NO 953832 A NO953832 A NO 953832A NO 953832 A NO953832 A NO 953832A NO 953832 D0 NO953832 D0 NO 953832D0
Authority
NO
Norway
Prior art keywords
iiia
inhibitors
cyclic compounds
glycoprotein iib
platelet glycoprotein
Prior art date
Application number
NO953832A
Other languages
Norwegian (no)
Other versions
NO953832L (en
Inventor
William Frank Degrado
Sharon Anne Jackson
Shaker Ahmed Mousa
Anju Parthasarathy
Michael Sworin
Maria Rafalski
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of NO953832D0 publication Critical patent/NO953832D0/en
Publication of NO953832L publication Critical patent/NO953832L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO953832A 1993-03-29 1995-09-28 Cyclic compounds which can be used as inhibitors of platelet glycoprotein IIb / IIIa NO953832L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3844893A 1993-03-29 1993-03-29
PCT/US1994/003223 WO1994022910A1 (en) 1993-03-29 1994-03-28 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa

Publications (2)

Publication Number Publication Date
NO953832D0 true NO953832D0 (en) 1995-09-28
NO953832L NO953832L (en) 1995-11-28

Family

ID=21900014

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953832A NO953832L (en) 1993-03-29 1995-09-28 Cyclic compounds which can be used as inhibitors of platelet glycoprotein IIb / IIIa

Country Status (10)

Country Link
EP (1) EP0691987A1 (en)
JP (1) JPH08508498A (en)
AU (1) AU6415894A (en)
CA (1) CA2159070A1 (en)
FI (1) FI954556A0 (en)
HU (1) HUT72896A (en)
NO (1) NO953832L (en)
NZ (1) NZ263456A (en)
PL (1) PL310896A1 (en)
WO (1) WO1994022910A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE174036T1 (en) * 1993-03-29 1998-12-15 Du Pont Merck Pharma PROCESS AND INTERMEDIATE COMPOUNDS FOR PRODUCING PLATES GLYCOPROTEIN IIB/IIIA INHIBITORS
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
BR9713141A (en) * 1996-11-27 2000-02-08 Rhone Poulenc Rorer Pharma Pharmaceutical composition process and kit for the treatment or prevention of a physiological condition associated with an ischemic disorder related to thrombosis and a patient, use of pharmaceutically effective amounts of a compound with anti-xa activity and a platelet aggregating antagonist compound, product containing these compounds, and, use of these compounds.
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
PT2118123E (en) 2007-01-31 2016-02-10 Harvard College Stabilized p53 peptides and uses thereof
WO2008121767A2 (en) 2007-03-28 2008-10-09 President And Fellows Of Harvard College Stitched polypeptides
KR102237243B1 (en) 2009-11-10 2021-04-07 알레그로 파마슈티칼스, 인코포레이티드. Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites
US11673914B2 (en) 2009-11-10 2023-06-13 Allegro Pharmaceuticals, LLC Peptide therapies for reduction of macular thickening
RU2582678C2 (en) 2010-08-13 2016-04-27 Эйлерон Терапьютикс, Инк. Peptidomimetic macrocycles
CA2835214C (en) 2011-05-09 2023-08-01 Allegro Pharmaceuticals, Inc. Integrin receptor antagonists and their methods of use
TWI643868B (en) 2011-10-18 2018-12-11 艾利倫治療公司 Peptidomimetic macrocycles
JP6450191B2 (en) 2012-02-15 2019-01-09 エイルロン セラピューティクス，インコーポレイテッド Peptide mimetic macrocycle
EP2819688A4 (en) 2012-02-15 2015-10-28 Aileron Therapeutics Inc Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
WO2014071241A1 (en) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
KR20170058424A (en) 2014-09-24 2017-05-26 에일러론 테라퓨틱스 인코포레이티드 Peptidomimetic macrocycles and uses thereof
KR102570210B1 (en) 2014-09-24 2023-08-23 에일러론 테라퓨틱스 인코포레이티드 Peptidomimetic macrocycles and formulations thereof
JP2018516844A (en) 2015-03-20 2018-06-28 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． Peptidomimetic macrocycles and uses thereof
US10023613B2 (en) 2015-09-10 2018-07-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of MCL-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2636066B1 (en) * 1988-09-02 1991-10-25 Centre Nat Rech Scient CYCLOPEPTIDE DERIVATIVES FOR USE AS SELECTIVE INHIBITORS AGAINST ACTIVE SERINE PROTEASES
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
AU6470590A (en) * 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
IL103252A (en) * 1991-09-30 1997-03-18 Du Pont Merck Pharma CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
FI954556A (en) 1995-09-26
PL310896A1 (en) 1996-01-08
HUT72896A (en) 1996-06-28
FI954556A0 (en) 1995-09-26
EP0691987A1 (en) 1996-01-17
CA2159070A1 (en) 1994-10-13
NZ263456A (en) 1996-11-26
WO1994022910A1 (en) 1994-10-13
HU9502832D0 (en) 1995-11-28
NO953832L (en) 1995-11-28
AU6415894A (en) 1994-10-24
JPH08508498A (en) 1996-09-10

Similar Documents

Publication Publication Date Title
NO953832D0 (en) Cyclic compounds which can be used as inhibitors of platelet glycoprotein IIb / IIIa
FI944804A (en) Pyrimidinylacetamide as elastase inhibitors
DK0606248T3 (en) Heteroberlamines as novel acetylcholinesterase inhibitors
NO973764L (en) Novel dipeptidamidines as thrombin inhibitors
FI946064A0 (en) Vaccine composition containing aids
NO951379L (en) Mixtures of hexahydrotriazines useful as H2S scavengers
DE69422575D1 (en) System for the explanation of exhibits
DE69431209T2 (en) TRANSDERMAL PROSTAGLANDIN COMPOSITION
FI941457A (en) Cyclic compounds useful as inhibitors of platelet glycoprotein IIb / IIIa
DE69520056D1 (en) Compounds to inhibit thrombin
ITMI930346A0 (en) PROCEDURE FOR THE PHOTOCHLORINATION OF ALKYLAROMATIC COMPOUNDS
NO922167L (en) AMINODECTS AS CORROSION INHIBITORS
DE69403489T2 (en) GAS PHASE METHOD FOR THE EPOXIDATION OF NON-ALLYLIC OLEFINS
MX9101181A (en) PROCESS FOR THE PREPARATION OF COMPOUNDS CONTAINING CYCLIC NITROGEN
DK0648738T3 (en) Process for the preparation of acetoacetarylamides
DK0584351T3 (en) Procedure for the protection of solid surfaces, in particular coastal areas, from contamination by hydrocarbons
FI961178A0 (en) Process for the preparation of cyclic cis-1-amino-2-alkanols
ZA927515B (en) Cyclic compounds useful as inhibitors of platelet glycoprotein IIb/IIIa
DE69716598T2 (en) STABILIZATION OF PAINTINGS BY SPIROINDER DERIVATIVES
DE69418254D1 (en) Calcium containing composition
NO921706L (en) NEW 2-BRAND CAPTOMETHYLENE-TETRAHYDRONE AFHALENE AND INDANE-2-CARBOXAMIDE DERIVATIVES AS ENCYPHALINASE INHIBITORS
ITMI931033A0 (en) PROCESS FOR THE PREPARATION OF GEMFIBROZIL
FI953495A0 (en) Packaging composition with improved stackability
DE69218093T2 (en) Process for the purification of 1,1,3,4,4,6-hexamethyltetralin
SE9301267D0 (en) of packing